{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:25:23Z","timestamp":1794579923350,"version":"4.9.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Primary Sj\u00f6gren\u2019s Syndrome (pSS) carries the highest risk for non-Hodgkin's lymphoma (NHL) development among systemic autoimmune diseases. However, the paucity of data on the long-term survival of those patients and the lack of established predictors for each lymphoma histologic subtype prompted our present study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We retrospectively analysed 121 patients diagnosed with NHL according to the WHO classification criteria. All patients fulfilled the 2016 ACR-EULAR classification criteria for pSS. Cumulative clinical, laboratory, radiologic, treatment regimens and histologic data were recorded, harmonized and analysed. Overall survival (OS) and event-free survival (EFS) curves were calculated. A mucosa-associated lymphoid tissue lymphoma (MALTL) prediction model was developed by applying innovative data-driven analysis of clinical features present at the time of pSS diagnosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>MALTLs constituted the majority of lymphomas (92\/121, 76.0%) followed by diffuse large B-cell lymphomas (DLBCL) (11\/121, 9.0%) and nodal marginal zone lymphomas (NMZL) (8\/121, 7%). MALTLs show salivary glands localization, limited disease and often bone marrow and nodal involvement. The 10-year OS and EFS rates were 79% and 45.5% for MALTLs, 40.9% and 24.2% for DLBCL and 46% and 31% for NMZL. Cryoglobulinemia, focus score and the total EULAR SS Disease Activity Index (ESSDAI) composite index at pSS diagnosis were proven independent MALTL predictors. Even though MALTLs have a comparatively good survival outlook, they are accompanied by frequent events throughout their clinical course.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Common features of pSS, present at diagnosis, can predict future lymphomagenesis meriting a more intensive follow-up plan.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab939","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T12:10:17Z","timestamp":1639743017000},"page":"3576-3585","source":"Crossref","is-referenced-by-count":69,"title":["Clinical picture, outcome and predictive factors of lymphoma in primary Sj\u00f6gren\u2019s syndrome: results from a harmonized dataset (1981\u20132021)"],"prefix":"10.1093","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2832-0116","authenticated-orcid":false,"given":"Loukas G","family":"Chatzis","sequence":"first","affiliation":[{"name":"Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens"},{"name":"Institute for Autoimmune Systemic and Neurologic Diseases , Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9977-4035","authenticated-orcid":false,"given":"Ioanna E","family":"Stergiou","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas V","family":"Goules","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens"},{"name":"Institute for Autoimmune Systemic and Neurologic Diseases , Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilis","family":"Pezoulas","sequence":"additional","affiliation":[{"name":"Unit of Medical Technology and Intelligent Information Systems, University of Ioannina , Ioannina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Tsourouflis","sequence":"additional","affiliation":[{"name":"Second Department of Propedeutic Surgery, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens , Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Fotiadis","sequence":"additional","affiliation":[{"name":"Unit of Medical Technology and Intelligent Information Systems, University of Ioannina , Ioannina"},{"name":"Department of Biomedical Research, Institute of Molecular Biology and Biotechnology, FORTH , Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios G","family":"Tzioufas","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens"},{"name":"Institute for Autoimmune Systemic and Neurologic Diseases , Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Voulgarelis","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,23]]},"reference":[{"key":"2022090108140823800_keab939-B1","doi-asserted-by":"crossref","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sj\u00f6gren syndrome","volume":"2","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2022090108140823800_keab939-B2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/1744666X.2021.1879641","article-title":"New frontiers in precision medicine for Sjogren's syndrome","volume":"17","author":"Chatzis","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"key":"2022090108140823800_keab939-B3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrrheum.2018.1","article-title":"B cells in the pathogenesis of primary Sj\u00f6gren syndrome","volume":"14","author":"Nocturne","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2022090108140823800_keab939-B4","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","article-title":"The risk of lymphoma development in autoimmune diseases: a meta-analysis","volume":"165","author":"Zintzaras","year":"2005","journal-title":"Arch Intern Med"},{"key":"2022090108140823800_keab939-B5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0002-9343(64)90101-9","article-title":"The development of malignant lymphoma in the course of Sjoegren's syndrome","volume":"36","author":"Talal","year":"1964","journal-title":"Am J Med"},{"issue":"Suppl 126","key":"2022090108140823800_keab939-B6","first-page":"125","article-title":"T cell lymphoma in the setting of Sj\u00f6gren's syndrome: T cells gone bad? Report of five cases from a single centre cohort","volume":"38","author":"Stergiou","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"2022090108140823800_keab939-B7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","article-title":"Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sj\u00f6gren's syndrome","volume":"46","author":"Ioannidis","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2022090108140823800_keab939-B8","doi-asserted-by":"crossref","first-page":"e0116189","DOI":"10.1371\/journal.pone.0116189","article-title":"Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients","volume":"10","author":"Papageorgiou","year":"2015","journal-title":"PLoS One"},{"key":"2022090108140823800_keab939-B9","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","article-title":"Lymphoma and other malignancies in primary Sj\u00f6gren's syndrome: a cohort study on cancer incidence and lymphoma predictors","volume":"65","author":"Theander","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2022090108140823800_keab939-B10","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/art.39518","article-title":"Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sj\u00f6gren's syndrome","volume":"68","author":"Nocturne","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2022090108140823800_keab939-B11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2022090108140823800_keab939-B12","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"2022090108140823800_keab939-B13","doi-asserted-by":"crossref","first-page":"e000022","DOI":"10.1136\/rmdopen-2014-000022","article-title":"EULAR Sj\u00f6gren's syndrome disease activity index (ESSDAI): a user guide","volume":"1","author":"Seror","year":"2015","journal-title":"RMD Open"},{"key":"2022090108140823800_keab939-B14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1183\/09059180.00001313","article-title":"Small airways diseases, excluding asthma and COPD: an overview","volume":"22","author":"Burgel","year":"2013","journal-title":"Eur Respir Rev"},{"key":"2022090108140823800_keab939-B15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nrneph.2015.174","article-title":"Renal involvement in primary Sj\u00f6gren syndrome","volume":"12","author":"Fran\u00e7ois","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"2022090108140823800_keab939-B16","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/jcp.21.5.656","article-title":"Labial salivary gland biopsy in Sj\u00f6gren's disease","volume":"21","author":"Chisholm","year":"1968","journal-title":"J Clin Pathol"},{"key":"2022090108140823800_keab939-B17","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","author":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project","year":"1993","journal-title":"N Engl J Med"},{"key":"2022090108140823800_keab939-B18","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1182\/blood-2017-03-771915","article-title":"A MALT lymphoma prognostic index","volume":"130","author":"Thieblemont","year":"2017","journal-title":"Blood"},{"key":"2022090108140823800_keab939-B19","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.3390\/jcm9082620","article-title":"Sj\u00f6gren's syndrome: the clinical spectrum of male patients","volume":"9","author":"Chatzis","year":"2020","journal-title":"J Clin Med"},{"key":"2022090108140823800_keab939-B20","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V","article-title":"Malignant lymphoma in primary Sj\u00f6gren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sj\u00f6gren's syndrome","volume":"42","author":"Voulgarelis","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2022090108140823800_keab939-B21","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/rheumatology\/kem079","article-title":"Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors","volume":"46","author":"Brito-Zer\u00f3n","year":"2007","journal-title":"Rheumatology"},{"key":"2022090108140823800_keab939-B22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/1756-185X.13800","article-title":"Characteristics of diffuse large B-cell lymphoma in patients with primary Sj\u00f6gren's syndrome","volume":"23","author":"Gorodetskiy","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"2022090108140823800_keab939-B23","doi-asserted-by":"crossref","first-page":"594096","DOI":"10.3389\/fimmu.2020.594096","article-title":"Primary Sj\u00f6gren's syndrome of early and late onset: distinct clinical phenotypes and lymphoma development","volume":"11","author":"Goules","year":"2020","journal-title":"Front Immunol"},{"key":"2022090108140823800_keab939-B24","first-page":"450","article-title":"Rate, risk factors and causes of mortality in patients with Sj\u00f6gren's syndrome: a systematic review and meta-analysis of cohort studies","volume":"55","author":"Singh","year":"2016","journal-title":"Rheumatology"},{"key":"2022090108140823800_keab939-B25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.semarthrit.2013.03.001","article-title":"Clinical features distinguishing lymphoma development in primary Sj\u00f6gren's Syndrome\u2013a retrospective cohort study","volume":"43","author":"Risselada","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"2022090108140823800_keab939-B26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13045-017-0464-5","article-title":"Characterization and risk estimate of cancer in patients with primary Sj\u00f6gren syndrome","volume":"10","author":"Brito-Zer\u00f3n","year":"2017","journal-title":"J Hematol Oncol"},{"key":"2022090108140823800_keab939-B27","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1200\/JCO.2016.70.6994","article-title":"Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: improved event-free and progression-free survival with rituximab plus chlorambucil versus either chlorambucil or rituximab monotherapy","volume":"35","author":"Zucca","year":"2017","journal-title":"J Clin Oncol"},{"key":"2022090108140823800_keab939-B28","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3389\/fonc.2019.01198","article-title":"Incidence and mortality trends and risk prediction nomogram for extranodal diffuse large B-cell lymphoma: an analysis of the surveillance, epidemiology, and end results database","volume":"9","author":"Yin","year":"2019","journal-title":"Front Oncol"},{"key":"2022090108140823800_keab939-B29","doi-asserted-by":"crossref","first-page":"e3766","DOI":"10.1097\/MD.0000000000003766","article-title":"Predicting the risk for lymphoma development in Sjogren syndrome: an easy tool for clinical use","volume":"95","author":"Fragkioudaki","year":"2016","journal-title":"Medicine"},{"key":"2022090108140823800_keab939-B30","doi-asserted-by":"crossref","first-page":"102648","DOI":"10.1016\/j.jaut.2021.102648","article-title":"A biomarker for lymphoma development in Sjogren's syndrome: salivary gland focus score","volume":"121","author":"Chatzis","year":"2021","journal-title":"J Autoimmun"},{"key":"2022090108140823800_keab939-B31","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.semarthrit.2020.07.013","article-title":"Cryoglobulinemic vasculitis in primary Sj\u00f6gren's syndrome: clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease","volume":"50","author":"Argyropoulou","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2022090108140823800_keab939-B32","first-page":"2376","article-title":"Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sj\u00f6gren's syndrome","volume":"24","author":"Valesini","year":"1997","journal-title":"J Rheumatol"},{"key":"2022090108140823800_keab939-B33","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MD.0b013e3181b76ab5","article-title":"Hematologic manifestations and predictors of lymphoma development in primary Sj\u00f6gren syndrome: clinical and pathophysiologic aspects","volume":"88","author":"Baimpa","year":"2009","journal-title":"Medicine"},{"key":"2022090108140823800_keab939-B34","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1093\/annonc\/mdu365","article-title":"Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study","volume":"25","author":"Fallah","year":"2014","journal-title":"Ann Oncol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab939\/42170044\/keab939.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/9\/3576\/45626655\/keab939.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/9\/3576\/45626655\/keab939.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T08:32:40Z","timestamp":1662021160000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/9\/3576\/6481570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,23]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,12,23]]},"published-print":{"date-parts":[[2022,8,30]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab939","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,1]]},"published":{"date-parts":[[2021,12,23]]}}}